The IPKat

JANUARY 31, 2023

The recent Board of Appeal decision in T 0670/20 considered whether patients in a clinical trial were under conditions of confidentiality. The question became whether the patients could be considered members of the public, and whether their participation in the clinical trial therefore constituted prior public use of the formulation.

Confidentiality 132

Confidentiality Public Use Patent Application Invention 132

Patently-O

AUGUST 13, 2021

In particular, the petition asks whether documents made available only to customers, and not generally to the public, count as being published. 21-193 (Supreme Court 2021). On balance, the Federal Circuit found the document “sufficiently disseminated” to count as a publication. 2021)(nonprecedential opinion).

Confidentiality 90

Confidentiality Advertising Advertising Invention 90

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. Note that FDA still has not designated any biosimilar as interchangeable to its reference product. January 2021. As noted above, companies are already taking advantage of these new designations. Introduction.

Litigation 52

Litigation Settlement Marketing Marketing 52